Aminoquanidine carboxylates for the treatment of obesity
US6166080A · kind A · utility
5Cited by
2References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 1997 |
| Grant date | Dec 26, 2000 |
| Priority date | — |
| Expiry date | May 22, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C281/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel compounds of the formulae (I): AG--(CH.sub.2).sub.n --CO.sub.2 R.sup.1 and (II) or pharmacologically acceptable salts thereof, wherein AG is: a) N-aminoguanidine, b) N,N'-diaminoguanidine, or c) N,N',N"-triaminoguanidine; and n, R.sup.1 and R.sup.2 have the meanings given in the description as well as a new use for the compounds of formula (III) wherein R.sup.3 has the meanings given in the description for the treatment of non-insulin dependent diabetes mellitus (NIDDM).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.